JP2023502625A5 - - Google Patents
Info
- Publication number
- JP2023502625A5 JP2023502625A5 JP2022527937A JP2022527937A JP2023502625A5 JP 2023502625 A5 JP2023502625 A5 JP 2023502625A5 JP 2022527937 A JP2022527937 A JP 2022527937A JP 2022527937 A JP2022527937 A JP 2022527937A JP 2023502625 A5 JP2023502625 A5 JP 2023502625A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025140331A JP2025176716A (ja) | 2019-11-15 | 2025-08-26 | 共有新抗原を標的にする抗原結合タンパク質 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962936303P | 2019-11-15 | 2019-11-15 | |
| US62/936,303 | 2019-11-15 | ||
| US202063030774P | 2020-05-27 | 2020-05-27 | |
| US63/030,774 | 2020-05-27 | ||
| PCT/US2020/060605 WO2021097365A2 (en) | 2019-11-15 | 2020-11-13 | Antigen-binding proteins targeting shared neoantigens |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025140331A Division JP2025176716A (ja) | 2019-11-15 | 2025-08-26 | 共有新抗原を標的にする抗原結合タンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502625A JP2023502625A (ja) | 2023-01-25 |
| JP2023502625A5 true JP2023502625A5 (https=) | 2023-11-21 |
| JPWO2021097365A5 JPWO2021097365A5 (https=) | 2023-11-21 |
Family
ID=75912393
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022527937A Pending JP2023502625A (ja) | 2019-11-15 | 2020-11-13 | 共有新抗原を標的にする抗原結合タンパク質 |
| JP2025140331A Pending JP2025176716A (ja) | 2019-11-15 | 2025-08-26 | 共有新抗原を標的にする抗原結合タンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025140331A Pending JP2025176716A (ja) | 2019-11-15 | 2025-08-26 | 共有新抗原を標的にする抗原結合タンパク質 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230041030A1 (https=) |
| EP (1) | EP4058484A4 (https=) |
| JP (2) | JP2023502625A (https=) |
| KR (1) | KR20220098379A (https=) |
| CN (1) | CN115175934A (https=) |
| AU (1) | AU2020384374A1 (https=) |
| CA (1) | CA3157411A1 (https=) |
| IL (1) | IL292535A (https=) |
| WO (1) | WO2021097365A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202000025SA (en) | 2017-07-14 | 2020-02-27 | Immatics Biotechnologies Gmbh | Improved dual specificity polypeptide molecule |
| KR20210119468A (ko) * | 2019-01-25 | 2021-10-05 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 돌연변이체 ras를 표적화하기 위한 조성물 및 방법 |
| WO2020172332A1 (en) | 2019-02-20 | 2020-08-27 | Fred Hutchinson Cancer Research Center | Binding proteins specific for ras neoantigens and uses thereof |
| EP4334361A1 (en) | 2021-05-05 | 2024-03-13 | Immatics Biotechnologies GmbH | Antigen binding proteins specifically binding prame |
| WO2023288203A2 (en) * | 2021-07-12 | 2023-01-19 | Ludwig Institute For Cancer Research Ltd | T cell receptors specific for tumor-associated antigens and methods of use thereof |
| WO2023044493A2 (en) * | 2021-09-17 | 2023-03-23 | Gritstone Bio, Inc. | Kras neoantigen therapies |
| CN118525037A (zh) * | 2021-10-29 | 2024-08-20 | 侯亚非 | 识别ctnnb1中s37f突变的t细胞受体及其应用 |
| WO2023086435A1 (en) * | 2021-11-10 | 2023-05-19 | Memorial Sloan-Kettering Cancer Center | T cell receptors targeting q61-comprising ras mutations and uses thereof |
| JP2025504883A (ja) * | 2022-01-21 | 2025-02-19 | テ－クニフェ ゲーエムベーハー | 決定可能な親和性で特定のペプチドを結合する抗原認識コンストラクト、およびｋｒａｓに抗原特異性を有するｔ細胞レセプター、ならびに、対応する核酸配列、ベクター、宿主細胞、医薬組成物、およびキット |
| WO2023173024A2 (en) * | 2022-03-10 | 2023-09-14 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of coronary artery disease by reducing activity of cross-reactive t cells |
| US20260055158A1 (en) * | 2022-08-08 | 2026-02-26 | The University Of North Carolina At Chapel Hill | Bioorthogonal t cell receptor molecules and methods of making and using the same |
| WO2024039576A2 (en) * | 2022-08-19 | 2024-02-22 | Memorial Sloan-Kettering Cancer Center | T cell receptors targeting ras mutations and uses thereof |
| EP4673167A1 (en) * | 2023-02-27 | 2026-01-07 | Adaptive Biotechnologies Corp. | Therapeutic t cell receptors targeting kras g12d |
| CN116350758B (zh) * | 2023-03-16 | 2024-08-06 | 郑州大学 | 肿瘤共享新抗原表位肽或其编码核酸在制备药物中的应用 |
| CN118909132A (zh) * | 2023-05-06 | 2024-11-08 | 北京鼎成肽源生物技术有限公司 | 靶向kras g12v突变的tcr分子和细胞及其应用 |
| IL304887A (en) * | 2023-07-31 | 2025-02-01 | Yeda Res & Dev | T-cell receptor directed against RAS neoantigen |
| WO2025056656A1 (en) * | 2023-09-15 | 2025-03-20 | Medigene Immunotherapies Gmbh | T-CELL RECEPTOR VARIANT AGAINST mKRAS7-16 G12V |
| WO2025056659A1 (en) * | 2023-09-15 | 2025-03-20 | Medigene Immunotherapies Gmbh | T-CELL RECEPTOR VARIANT AGAINST mKRAS7-16 G12V AND G12C |
| WO2025189363A1 (zh) * | 2024-03-12 | 2025-09-18 | 广州医科大学 | 一种t细胞受体(tcr)及其用途 |
| WO2025240737A1 (en) * | 2024-05-16 | 2025-11-20 | Rutgers, The State University Of New Jersey | Methods of producing memory t cells in vitro and their use in immunotherapy |
| WO2025259799A2 (en) * | 2024-06-12 | 2025-12-18 | Biontech Us Inc. | T cell receptor compositions and methods of use thereof |
| WO2026057812A1 (en) * | 2024-09-12 | 2026-03-19 | Medigene Immunotherapies Gmbh | T-cell receptor variant against mkras 7-16 g12d |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013040142A2 (en) * | 2011-09-16 | 2013-03-21 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| WO2013190090A1 (en) * | 2012-06-21 | 2013-12-27 | Philip Morris Products S.A. | Gene signatures for classifying and grading lung cancer |
| MX384919B (es) * | 2014-11-26 | 2025-03-14 | Us Health | Receptores de células t de kras anti-mutado. |
| WO2016154047A2 (en) * | 2015-03-20 | 2016-09-29 | Memorial Sloan-Kettering Cancer Center | Monoclonal antigen-binding proteins to intracellular oncogene products |
| CN115873129A (zh) * | 2015-03-23 | 2023-03-31 | 约翰·霍普金斯大学 | 由体细胞突变基因编码的hla限制性表位 |
| TW202523682A (zh) * | 2015-05-20 | 2025-06-16 | 美商博德研究所有限公司 | 共有之gata3相關之腫瘤特異性新抗原 |
| TW201702272A (zh) * | 2015-05-22 | 2017-01-16 | 美國紀念斯隆 凱特琳癌症中心 | Ｐｒａｍｅ肽專一性類ｔ細胞受體抗體 |
| AU2018318303A1 (en) * | 2017-08-18 | 2020-04-09 | Gritstone Bio, Inc. | Antigen-binding proteins targeting shared antigens |
| CN112368386A (zh) * | 2018-05-23 | 2021-02-12 | 磨石肿瘤生物技术公司 | 共有抗原 |
-
2020
- 2020-11-13 AU AU2020384374A patent/AU2020384374A1/en active Pending
- 2020-11-13 WO PCT/US2020/060605 patent/WO2021097365A2/en not_active Ceased
- 2020-11-13 CA CA3157411A patent/CA3157411A1/en active Pending
- 2020-11-13 IL IL292535A patent/IL292535A/en unknown
- 2020-11-13 KR KR1020227019577A patent/KR20220098379A/ko active Pending
- 2020-11-13 JP JP2022527937A patent/JP2023502625A/ja active Pending
- 2020-11-13 CN CN202080085181.6A patent/CN115175934A/zh active Pending
- 2020-11-13 EP EP20886309.2A patent/EP4058484A4/en active Pending
-
2022
- 2022-05-13 US US17/744,354 patent/US20230041030A1/en active Pending
-
2025
- 2025-08-26 JP JP2025140331A patent/JP2025176716A/ja active Pending